Marex Group’s Zimmer Biomet ZBH Stock Holding History

Marex Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,000	Closed	-$493K	–	1163
2025 Q3	$493K	Buy	+5,000	New	+$495K	﹤0.01%	502
2024 Q3	–	Sell	-46,800	Closed	-$5.08M	–	774
2024 Q2	$5.08M	Buy	+46,800	New	+$5.52M	0.14%	93

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Marex Group's ZBH Position: Q4 2025 in Review

Marex Group sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 5,000 shares — an estimated $493K sold.

Marex Group first reported a position in ZBH in Q2 2024 and held it in 2 quarters. The position peaked at $5.08M in Q2 2024. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

Marex Group reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
Marex Group sold 5,000 Zimmer Biomet shares in Q4 2025, an estimated $493K.
Marex Group first reported a position in Zimmer Biomet in Q2 2024 and held it in 2 quarters.
Marex Group's Zimmer Biomet position peaked at $5.08M in Q2 2024.
945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.